Madhya Pradesh Doctor Who Prescribed Deadly Cough Syrup To Children Arrested

The Madhya Pradesh government also filed a case against Srisan Pharmaceuticals, the company that manufactured the Coldrif syrup.

Bhopal: The doctor in Madhya Pradesh’s Chhindwara who prescribed Coldrif syrup to children has been arrested amid a massive row over the deaths of 11 children who allegedly took the contaminated cough syrups, officials said early Sunday. Most of the children were treated at the clinic of Praveen Soni, a paediatrician in Parasia.

Soni, a government doctor who prescribed the syrup to children during their visit to his private clinic, was also suspended.

The Madhya Pradesh government also filed a case against Srisan Pharmaceuticals, a company based in Tamil Nadu’s Kanchipuram district that manufactured the Coldrif cough syrup.

The government had earlier banned the sale of Coldrif, with officials saying that samples of the drug were found to contain 48.6 % diethylene glycol, a highly toxic substance. A sample of the syrup, tested by the government drug analyst at the Drug Testing Laboratory in Chennai, was declared “Not of Standard Quality” by the Tamil Nadu Directorate of Drug Control.

As a precautionary measure, the local administration banned the sale of Coldrif and another cough syrup, ‘Nextro-DS’, on Monday. The test report for Coldrif arrived on Saturday, while that of Nextro-DS is awaited.

According to distraught families, the children first complained of a cold and mild fever in early September. They were then prescribed routine medication, including cough syrups, after which they seemed to recover. But within days, the symptoms returned, followed by a sudden and alarming decrease in urine output. Their condition then worsened into kidney infections, and they later died.

Kidney biopsies then revealed the presence of diethylene glycol contamination.

Chief Minister Mohan Yadav called the deaths “extremely tragic” and said strict action will be taken against those responsible.

“The deaths of children in Chhindwara due to Coldrif syrup are extremely tragic. The sale of this syrup has been banned across Madhya Pradesh. A ban is also being imposed on the sale of other products from the company that manufactures the syrup,” he wrote on X on Saturday.

He said they asked the Tamil Nadu government to test Coldrif as the factory producing the syrup is located in Kanchipuram.

Related Posts

CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

Milan: CPHI Milan 2026, one of the pharmaceutical industry’s largest global events, has launched four specialist zones designed to connect pharmaceutical companies with the technologies, services and expertise shaping the…

Lilly takes 6 companies to court for selling retatrutide knockoffs

Washington: Eli Lilly’s experimental weight-loss drug retatrutide has yet to be approved by the FDA. But the buzz surrounding the effectiveness of the compound—commonly known as triple-G—has already triggered a…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

Lilly takes 6 companies to court for selling retatrutide knockoffs

Lilly takes 6 companies to court for selling retatrutide knockoffs

FDA Busts Abortion Medicine Racket in Nagpur, Solapur; IndiaMART Directors among 8 Booked

FDA Busts Abortion Medicine Racket in Nagpur, Solapur; IndiaMART Directors among 8 Booked

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch